Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers
A Prospective, Randomized Controlled Trial Evaluating the Effectiveness of the Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System in the Acute Post-Operative Management of Surgically Closed Pressure Ulcers
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Secondary Objectives:
- Compare the complication rate in each treatment group during the acute postoperative period (2 weeks).
- Comparisons of the inflammatory and bacterial microbiomes of pressure ulcers following surgical therapy.
- Comparisons of baseline patient characteristics and their relationship to both early and late pressure ulcer recurrence, and complication rates.
- Assessment of outcomes and complications associated with flap technique and surgeon guided descriptions of the operative closure.
- Compare the absolute costs associated with the FIS System against AFB system.
- Compare the acceptance of each system by subjects and nursing staff, including the parameter of patient comfort at 7 and 14 days postoperative.
- Assessing the incidence of complications and additional treatments needed following the two week study period.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jing Liu, MD
- Phone Number: 3126953908
- Email: jing-liu@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Memorial Hospital Plastic Surgery
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- will be admitted as an inpatient
- is ≥ 18 years of age and ≤ 85 years of age at time of consent
- is able to provide his/her own informed consent
- is deemed by the investigators to be reasonably compliant
- has a pressure ulcer meeting criteria for stage III or IV
- has not participated in a clinical trial within the past 30 days
- has a 30-day wound history available if the wound has been previously treated
Exclusion Criteria:
- has a life expectancy of < 12 months
- is not healthy enough to undergo surgery for any reason
- has a history of radiation therapy
- is, in the opinion of the investigator, noncompliant
- has a history of > 3 closures of pressure ulcers in the same site
- has a history of a bleeding disorder
- has severe fecal incontinence
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Fluid Immersion Simulation System (FIS)
Pressure ulcer patients are assigned to Fluid Immersion Simulation System (Dolphin) after operative debridement and closure.
|
Dolphin Fluid Immersion Simulation® System Mattress will be used
Other Names:
|
|
Active Comparator: Air Fluidized Bed System (AFB)
Pressure ulcer patients are assigned to Air Fluidized Bed (Clinitron) after operative debridement and closure
|
Air Fluidized Bed (Clinitron) will be used.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants With Successful Closure of Wound at 2 Weeks After Surgery
Time Frame: 2 weeks
|
Comparison of successful closure of wound at 2 weeks after surgery between treatment groups.
|
2 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Complications
Time Frame: 2 weeks
|
Comparison of complication rate, including dehiscence, necrosis, maceration, and seromas between treatment groups.
These are gathered via the patient's medical chart and interaction with the Principle Investigator (their physician).
|
2 weeks
|
|
Differences in Quantitative Patient Survey Responses: Acceptability
Time Frame: 2 weeks
|
Differences in quantitative patient survey responses regarding acceptability.
This scale includes three subscales: 1) comfort, 2) difficulty with mobilization, and 3) pain at surgical site.
Each subscale is graded on a scale of 1-5 with 1 being "better" (i.e.
very comfortable, no difficulty, or no pain) and 5 being "worse" (i.e.
very uncomfortable, extreme difficulty, or extreme pain).
Subscales will be combined to compute a total score by averaging the sum of each of the three subscales.
The total score indicates patient acceptability on a scale of 1-5 with 1 being "better" (very acceptable) and 5 being "worse" (not acceptable).
|
2 weeks
|
|
Differences in Quantitative Nurse Survey Responses
Time Frame: 2 weeks
|
Differences in quantitative nurse survey responses regarding acceptability and tolerance of each therapeutic modality, including patient comfort.
This survey includes three subscales: 1) ease of use, 2) amount of training required, and 3) Time Required for Troubleshooting or Otherwise Occupied by Device.
Each subscale is graded on a scale of 1-5 with 1 being "better" (i.e.
no difficulty, no training, or no time) and 5 being "worse" (i.e.
extreme difficulty, very high amount of training, or >30 minutes a day).
Subscales will be combined to compute a total score by averaging the sum of each of the three subscales.
The total score indicates nurse acceptability on a scale of 1-5 with 1 being "better" (very acceptable) and 5 being "worse" (not acceptable).
|
2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Robert D Galiano, MD, Northwestern Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STU00200584
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.